{
    "2020-03-30": [
        [
            {
                "time": "2023-03-15",
                "original_text": "FDA Decisions on 5 Drugs Expected in 2nd Quarter",
                "features": {
                    "keywords": [
                        "FDA",
                        "Decisions",
                        "Drugs",
                        "2nd Quarter"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "There's scant evidence for chloroquine so far as a COVID-19 drug. But there's already a shortage",
                "features": {
                    "keywords": [
                        "chloroquine",
                        "COVID-19",
                        "shortage"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "Novartis Reports Data on Inclisiran, CHMP Positive on Zolgensma",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Inclisiran",
                        "CHMP",
                        "Zolgensma"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "FDA approves emergency use of malaria pill for COVID-19 treatment",
                "features": {
                    "keywords": [
                        "FDA",
                        "emergency use",
                        "malaria pill",
                        "COVID-19"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}